Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
- PMID: 22348189
- PMCID: PMC3279322
- DOI: 10.4084/MJHID.2012.007
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs
Abstract
We report pharmacokinetic data on two gastrectomized, patients affected by tuberculosis. Drugs plasmatic concentrations were measured after seven days of oral therapy by a validated high performance liquid chromatography-mass spectrometry (HPLC-MS) method and the area under the concentration-time-curve (AUC) over 24 hours (AUC(0-24)) was calculated. A sub-therapeutic level of isoniazid was found in a patient with total gastrectomy with a C(max) of 0,395 mg\L and AUC(0-24) level of 4.75 hr*mg/L. The level of the other antitubercular drugs was adequate. These findings support the need to monitor anti tubercular drug levels to facilitate early detection of therapeutic failure, above all in patients treated with isoniazid and with potential problems on oral drugs absorption.
Similar articles
-
Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.Clin Ther. 2013 Feb;35(2):161-8. doi: 10.1016/j.clinthera.2013.01.003. Clin Ther. 2013. PMID: 23410999 Clinical Trial.
-
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs.J Antimicrob Chemother. 2015 Sep;70(9):2572-5. doi: 10.1093/jac/dkv148. Epub 2015 Jun 11. J Antimicrob Chemother. 2015. PMID: 26066583
-
Pharmacokinetics of single-dose and multiple-dose memantine in healthy chinese volunteers using an analytic method of liquid chromatography-tandem mass spectrometry.Clin Ther. 2008 Apr;30(4):641-53. doi: 10.1016/j.clinthera.2008.04.005. Clin Ther. 2008. PMID: 18498913 Clinical Trial.
-
Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.Eur J Clin Pharmacol. 2016 Aug;72(8):905-16. doi: 10.1007/s00228-016-2083-4. Epub 2016 Jun 15. Eur J Clin Pharmacol. 2016. PMID: 27305904 Review.
-
Therapeutic drug monitoring in the treatment of tuberculosis.Drugs. 2002;62(15):2169-83. doi: 10.2165/00003495-200262150-00001. Drugs. 2002. PMID: 12381217 Review.
Cited by
-
Review of evidence for measuring drug concentrations of first-line antitubercular agents in adults.Clin Pharmacokinet. 2014 Oct;53(10):873-90. doi: 10.1007/s40262-014-0170-1. Clin Pharmacokinet. 2014. PMID: 25172553 Review.
References
-
- Kayano Y, Horiuchi I, Mori YI, Ishida K, Saito T, Taguchi M, Hashimoto Y. A simulation study to evaluate limited sampling strategies to estimate area under the curve of drug oncentration versus time following repetitive oral dosing: limited sampling model versus naive trapezoidal method. Biol Pharm Bull. 2009;32:1486–90. doi: 10.1248/bpb.32.1486. - DOI - PubMed
-
- Um SW, Lee SW, Kwon SY, Yoon HI, Park KU, Song J, et al. Low serum concentrations of anti-tuberculosis drugs and determinants of their serum levels. Int J Tuberc Lung Dis. 2007;11:972–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources